CLX — The Clorox Balance Sheet
0.000.00%
- $10.42bn
- $15.59bn
- $6.72bn
Annual balance sheet for The Clorox, fiscal year end - June 30th, USD millions except per share, conversion factor applied.
2022 June 30th | 2023 June 30th | 2024 June 30th | 2025 June 30th | 2026 June 30th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Cash and Short Term Investments | 183 | 367 | 202 | 167 | 143 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 681 | 688 | 695 | 821 | 791 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 1,725 | 1,828 | 1,622 | 1,608 | 1,824 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 1,694 | 1,720 | 1,708 | 1,635 | 1,986 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Other Long Term Assets | |||||
| Total Assets | 6,158 | 5,945 | 5,751 | 5,561 | 7,794 |
| Accounts Payable | |||||
| Payable / Accrued | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 1,784 | 1,917 | 1,574 | 1,919 | 2,773 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Minority Interest | |||||
| Total Other Liabilities | |||||
| Total Funded Status | |||||
| Total Liabilities | 5,602 | 5,725 | 5,423 | 5,240 | 7,704 |
| Non Redeemable Preferred Stock | |||||
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Treasury Stock | |||||
| Other Equity | |||||
| Total Equity | 556 | 220 | 328 | 321 | 90 |
| Total Liabilities & Shareholders' Equity | 6,158 | 5,945 | 5,751 | 5,561 | 7,794 |
| Total Common Shares Outstanding |